Peter Attia· MD
on the one hand improved technology enables us to collect much more data on patients than ever before and patients themselves are better able to monitor their own biomarkers this is good even better artificial intelligence and machine learning are being harnessed to try to digest this massive perfusion of data and come up with more definitive assessments of our risk of say heart disease then the rather simple risk factor-based calculators we have now